SEC Filing Summary: AspenBio Pharma, Inc.
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on August 12, 2010. The registrant is incorporated in Colorado and maintains its principal executive offices in Castle Rock, Colorado. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Note: The request metadata referenced "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as "AspenBio Pharma, Inc."
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure notice regarding a presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The report focuses solely on the dissemination of information via a presentation.
Guidance, Outlook, and Management Commentary
- Regulation FD Disclosure: The company is furnishing a PowerPoint presentation (Exhibit 99.1) under Item 7.01.
- Event Context: The presentation was scheduled for its first use at the CANACCORD/Genuity 30th Annual Growth Conference on August 12, 2010.
- Availability: The presentation is incorporated by reference and is available on the Company's website.
Key Facts for Investor Verification
- Verify the content of the "Power Point Presentation" (Exhibit 99.1) referenced in the filing, as the financial details are contained therein rather than in the 8-K text.
- Confirm the company name is AspenBio Pharma, Inc., not Riot Platforms, Inc.
- Check the company website for the archived presentation dated August 12, 2010.
- Note that no audited financial data is included in this specific filing.